1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
2024) In Diabetes Care(
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
2024) In Diabetologia(
- Contribution to journal › Article
- 2023
-
Mark
Refining the Definition of Stage 1 Type 1 Diabetes : An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
(
- Contribution to journal › Article
-
Mark
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
(
- Contribution to journal › Article
-
Mark
Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity
(
- Contribution to journal › Article
- 2022
-
Mark
Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
(
- Contribution to journal › Article
-
Mark
Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals with Presymptomatic Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
(
- Contribution to journal › Article
- 2021
-
Mark
Imputing Longitudinal Growth Data in International Pediatric Studies : Does CDC Reference Suffice?
(
- Contribution to journal › Article
-
Mark
DPVis : Visual Analytics with Hidden Markov Models for Disease Progression Pathways
(
- Contribution to journal › Article